Albireo Pharma Operating Expenses 2011-2026 | ALBO

Annual Operating Expenses Albireo Pharma

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
163 M	105 M	70.7 M	50.6 M	24.6 M	14 M	19.8 M	19.3 M	20.6 M	19.3 M	23.2 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
163 M	14 M	48.1 M

Quarterly Operating Expenses Albireo Pharma

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	42.4 M	35.5 M	41.7 M	-	29.2 M	20.1 M	31.1 M	-	22 M	16.5 M	15.9 M	-	12.9 M	11.1 M	11.8 M	-	6.53 M	6.61 M	6.1 M	-	3.47 M	6.03 M	2.75 M	3.23 M	16.3 M	6.58 M	4.53 M	5.24 M	15.6 M	4.75 M	5.24 M	5.04 M	16.2 M	5.22 M	5.04 M	5.91 M	13.6 M	4.73 M	5.91 M	4.37 M	18.6 M	5.32 M	4.37 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
42.4 M	2.75 M	12.6 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
AgeX Therapeutics AGE	10.1 M	-	-10.17 %	$ 12.2 K	USA
Aytu BioScience AYTU	53.7 M	$ 2.71	1.88 %	$ 17 M	USA
Amphastar Pharmaceuticals AMPH	168 M	$ 25.87	-0.79 %	$ 1.25 B	USA
Alterity Therapeutics Limited ATHE	16.7 M	$ 3.31	-4.06 %	$ 7.96 B	Australia
Aptose Biosciences APTO	26.3 M	-	-45.71 %	$ 1.2 M	Canada
Aravive ARAV	80 M	-	-13.39 %	$ 1.45 M	USA
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
AVROBIO AVRO	71.7 M	-	1083.1 %	$ 745 M	USA
Aeglea BioTherapeutics AGLE	209 M	-	-	$ 1.01 B	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Brickell Biotech BBI	14.4 M	-	-5.38 %	$ 6.06 M	USA
BioLineRx Ltd. BLRX	28.1 M	$ 2.97	3.12 %	$ 908 M	Israel
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Ascendis Pharma A/S ASND	338 M	$ 215.29	4.59 %	$ 5 B	Danmark
BioNTech SE BNTX	512 M	$ 105.97	-2.78 %	$ 27.2 B	Germany
Bellicum Pharmaceuticals BLCM	28.5 M	-	-9.72 %	$ 5.89 M	USA
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Bio-Path Holdings BPTH	15.8 M	-	-	$ 100 K	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
Baudax Bio BXRX	54.6 M	-	0.59 %	$ 63 K	USA
Arrowhead Pharmaceuticals ARWR	731 M	$ 64.74	1.41 %	$ 8.66 B	USA
Can-Fite BioPharma Ltd. CANF	14 M	$ 3.96	-1.0 %	$ 8.62 B	Israel
Burford Capital Limited BUR	106 M	$ 9.63	-0.93 %	$ 1.56 B	Britain
CASI Pharmaceuticals CASI	38.9 M	$ 0.95	-0.72 %	$ 129 M	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Adaptimmune Therapeutics plc ADAP	141 M	-	-15.15 %	$ 60.3 M	Britain
Celldex Therapeutics CLDX	58.1 M	$ 25.15	-1.95 %	$ 1.62 M	USA
AIkido Pharma AIKI	29.7 M	-	1.93 %	$ 17.4 M	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
AlloVir ALVR	65.4 M	-	4.14 %	$ 49.1 M	USA
Catalyst Biosciences CBIO	176 M	$ 14.01	3.7 %	$ 922 M	USA
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
Biogen BIIB	5.39 B	$ 164.87	0.27 %	$ 24 B	USA
Avid Bioservices CDMO	26 M	-	-	$ 789 M	USA
BioVie BIVI	18.1 M	$ 1.23	2.07 %	$ 1.82 M	USA
Catalyst Pharmaceuticals CPRX	190 M	$ 23.32	2.71 %	$ 2.76 B	USA
Calithera Biosciences CALA	125 M	-	-10.95 %	$ 876 K	USA